Skip to main content

Table 4 Cost* of herpes zoster and postherpetic neuralgia at 1 month

From: Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the valencian community of Spain

   TPP perspective** Societal perspective‡
Direct costsϕ   Total Mean SD Total Mean SD
Primary care visits With PHN 6,686.34 111.44 69.02 6,686.34 111.44 69.02
  Without PHN 4,834.90 69.07 31.29 4,834.90 69.07 31.29
Primary care emergencies With PHN 4,173.50 69.56 111.00 4,173.50 69.56 111.00
  Without PHN 3,004.92 42.93 56.38 3,004.92 42.93 56.38
Specialist visits With PHN 1,301.86 21.70 57.33 1,301.86 21.70 57.33
  Without PHN 424.62 6.07 18.33 424.62 6.07 18.33
Other professional visits With PHN 629.66 10.49 68.62 629.66 10.49 68.62
  Without PHN 33.14 0.47 2.78 33.14 0.47 2.78
Hospitalizations With PHN 0 0 -- 0 0 --
  Without PHN 0 0 -- 0 0 --
Hospital emergencies With PHN 2,060.80 34.35 72.65 2,060.80 34.35 72.65
  Without PHN 309.12 4.42 21.02 309.12 4.42 21.02
Diagnostic tests With PHN 438.75 7.31 17.35 438.75 7.31 17.35
  Without PHN 186.50 2.66 9.73 186.50 2.66 9.73
Medication With PHN 8,626.16 143.77 177.84 10,923.44 182.06 182.45
  Without PHN 4,817.45 68.82 55.59 7,191.82 102.74 65.79
Indirect cost#       
Absenteeism from work With PHN 2,706.18 45.10 200.92 6,686.22 111.44 461.46
  Without PHN 0 0 0 201.14 2.87 9.94
Carers † With PHN 0 0 0 73.14 1.22 9.44
  Without PHN 0 0 0 0 0 0
  1. * In 2007 euros.
  2. Other professionals: physiotherapist, nurses and alternative medical practitioners.
  3. † Carers: those persons or relatives who took care of herpes zoster patients.
  4. ** TPP Perspective (Third-Party Payer = Spanish Social Security): public medical visits + diagnostic test + percentage that Spanish National Health System pays for prescriptions.
  5. ‡ Societal perspective: TPP perspective items + percentage that patient pay for prescription + private medical visits + medication not included in the Spanish National System + cost for lost hours of work.
\